Taken together, this suggested that the deletion of TOX mainly impairs pancreatic β cell differentiation, whereas the deletion of DLK1 and RASGRP1 might contribute to T1D progression through both impairing pancreatic β cell differentiation and elevating apoptosis. Here, RASGRP1 is linked to type 1 diabetes mellitus.